GYNECOLOGIC CANCERS

Latest News

Nivolumab Shows Promising Efficacy in dMMR Uterine and Ovarian Cancers
Nivolumab Shows Promising Efficacy in dMMR Uterine and Ovarian Cancers

July 11th 2024

A phase 2 trial demonstrated that nivolumab is effective and has a manageable safety profile in patients with mismatch repair deficiency uterine or ovarian cancers.

Achieving High-Quality Care for Patients With Ovarian Cancer
Achieving High-Quality Care for Patients With Ovarian Cancer

June 10th 2024

Nivolumab/Ipilimumab in Ovarian/GYN Clear Cell Carcinoma Shows Survival and Response Benefit
Nivolumab/Ipilimumab in Ovarian/GYN Clear Cell Carcinoma Shows Survival and Response Benefit

June 2nd 2024

Estrogen Therapy Alone Raises Ovarian/Endometrial Cancer Risk in Postmenopausal Women After Hysterectomy
Estrogen Therapy Alone Raises Ovarian/Endometrial Cancer Risk in Postmenopausal Women After Hysterectomy

May 23rd 2024

Biomarker-Focused Strategies Improve Outcomes in Gynecologic Malignancies
Biomarker-Focused Strategies Improve Outcomes in Gynecologic Malignancies

April 27th 2024